Continuous subcutaneous insulin infusion providing better glycemic control and quality of life in Type 2 diabetic subjects hospitalized for marked hyperglycemia

Journal of Evaluation in Clinical Practice

Volumn 16, Issue 1, 2010, Pages 202-205

  Lee, I Te ^a,b   Liau, Yi Ju ^c   Lee, Wen Jane ^a   Huang, Chien Ning ^b   Sheu, Wayne H H ^a,b,d  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c JEN AI HOSPITAL   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN;

ADULT; BEDTIME DOSAGE; BLOOD GLUCOSE MONITORING; BOLUS INJECTION; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; COLD SWEAT; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFUSION PUMP; INSULIN PUMP; INSULIN TREATMENT; LETTER; LOADING DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; SYRINGE; TAIWAN;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; TAIWAN;

EID: 77149172037     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2009.01134.x     Document Type: Letter

References (17)

1. The Diabetes Control and Complications Trial Research group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329 (14 977 986.
2. Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N. Shichiri, M. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Research and Clinical Practice, 28 (2 103 117.
3. UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352 (9131 837 853.
4. Pickup, J. Keen, H. (2002) Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care, 25 (3 593 598.
5. King, H., Aubert, R. E. Herman, W. H. (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care, 21 (9 1414 1431.
6. Rossetti, L., Giaccari, A. DeFronzo, R. A. (1990) Glucose toxicity. Diabetes Care, 13 (6 610 630.
7. Jennings, A. M., Lewis, K. S., Murdoch, S., Talbot, J. F., Bradley, C. Ward, J. D. (1991) Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas. Diabetes Care, 14 (8 738 744.
8. Nielson, C. P. Hindson, D. A. (1989) Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes, 38 (8 1031 1035.
9. Kawano, H., Motoyama, T., Hirashima, O., Hirai, N., Miyao, Y., Sakamoto, T., Kugiyama, K., Ogawa, H. Yasue, H. (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. Journal of the American College of Cardiology, 34 (1 146 154.
10. Parsons, M. W., Li, T., Barber, P. A., Yang, Q., Darby, D. G., Desmond, P. M., Gerraty, R. P., Tress, B. M. Davis, S. M. (2000) Combined (1) H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology, 55 (4 498 505.
11. Valensi, P., Moura, I., Le Magoarou, M., Paries, J., Perret, G. Attali, J. R. (1997) Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment. Diabetes and Metabolism, 23 (1 51 57.
12. Pouwels, M. J., Tack, C. J., Hermus, A. R. Lutterman, J. A. (2003) Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant type 2 diabetic patients. Diabetic Medicine, 20 (1 76 79.
13. Ilkova, H., Glaser, B., Tunckale, A., Bagriacik, N. Cerasi, E. (1997) Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 20 (9 1353 1356.
14. American Diabetes Association (2007) Standards of medical care in diabetes. Diabetes Care, 30 (Suppl. 1 S4 S41.
15. Peyrot, M. Rubin, R. R. (2005) Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating Questionnaire. Diabetes Care, 28 (1 53 58.
16. Raskin, P., Bode, B. W., Marks, J. B., Hirsch, I. B., Weinstein, R. L., McGill, J. B., Peterson, G. E., Mudaliar, S. R. Reinhardt, R. R. (2003) Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care, 26 (9 2598 2603.
17. Ryan, E. A., Imes, S. Wallace, C. (2004) Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care, 27 (5 1028 1032.